Viewing stories from February, 2015
Starpharma presents at ASX Investor Series
Starpharma is presenting to more than 200 investors at ASX Investor Series event in Sydney.
The ASX Investor Series is hosted by the ASX in conjunction with Finance News Network (FNN) and is designed to engage the investment community and bring together ASX-listed companies, investors and financial market participants.
Interim Report and Half-Year Financial Results
Starpharma today released its interim report and financial results for the half-year ended 31 December 2014.
Financial Summary
- Reported loss of $8.5M (Dec 2013: $5.6M)
- Cash position at 31 December 2014 of $39.3M
- R&D tax incentives of $1.6M reported in the half-year (Dec 2013: $2.6M)
- Receipt of $4.2M R&D tax incentive refund
- $20.5M net proceeds from equity placement and share purchase plan